Volume 15, Issue 6, Pages (May 2016)

Slides:



Advertisements
Similar presentations
Volume 11, Issue 4, Pages (April 2007)
Advertisements

Volume 5, Issue 6, Pages (December 2015)
Volume 3, Issue 1, Pages (July 2008)
Volume 138, Issue 2, Pages (February 2010)
Volume 56, Issue 1, Pages (October 2014)
Volume 5, Issue 6, Pages (December 2013)
Volume 4, Issue 4, Pages (April 2015)
Volume 2, Issue 5, Pages (May 2014)
Volume 14, Issue 1, Pages (January 2014)
Volume 9, Issue 5, Pages (November 2017)
Direct Conversion of Mouse Fibroblasts into Neural Stem Cells by Chemical Cocktail Requires Stepwise Activation of Growth Factors and Nup210  Yuewen Tang,
Volume 28, Issue 2, Pages (August 2015)
Volume 3, Issue 5, Pages (November 2014)
Molecular Therapy - Nucleic Acids
Volume 9, Issue 3, Pages (September 2017)
A Constitutive Intrinsic Inflammatory Signaling Circuit Composed of miR-196b, Meis2, PPP3CC, and p65 Drives Prostate Cancer Castration Resistance  Ji-Hak.
Volume 13, Issue 1, Pages (July 2013)
Volume 5, Issue 1, Pages (July 2015)
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
Volume 6, Issue 1, Pages (January 2016)
Volume 9, Issue 3, Pages (September 2017)
Kenichi Miharada, Valgardur Sigurdsson, Stefan Karlsson  Cell Reports 
Fig. 4. miR-370 restoration suppressed EMT progression in HCC cells
Molecular Mechanisms Regulating the Defects in Fragile X Syndrome Neurons Derived from Human Pluripotent Stem Cells  Tomer Halevy, Christian Czech, Nissim.
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 18, Issue 10, Pages (March 2017)
HBL1 Is a Human Long Noncoding RNA that Modulates Cardiomyocyte Development from Pluripotent Stem Cells by Counteracting MIR1  Juli Liu, Yang Li, Bo Lin,
Promotion Effects of miR-375 on the Osteogenic Differentiation of Human Adipose- Derived Mesenchymal Stem Cells  Si Chen, Yunfei Zheng, Shan Zhang, Lingfei.
Volume 1, Issue 6, Pages (December 2013)
Volume 9, Issue 5, Pages (November 2017)
Jamie A. Hackett, Toshihiro Kobayashi, Sabine Dietmann, M. Azim Surani 
Volume 16, Issue 9, Pages (August 2016)
Volume 4, Issue 4, Pages (April 2015)
Volume 5, Issue 5, Pages (November 2015)
HBL1 Is a Human Long Noncoding RNA that Modulates Cardiomyocyte Development from Pluripotent Stem Cells by Counteracting MIR1  Juli Liu, Yang Li, Bo Lin,
Volume 3, Issue 6, Pages (December 2014)
Volume 5, Issue 3, Pages (September 2015)
Volume 8, Issue 5, Pages (May 2017)
Volume 7, Issue 6, Pages (December 2016)
ADAR Regulates RNA Editing, Transcript Stability, and Gene Expression
An RNAi Screen of Chromatin Proteins Identifies Tip60-p400 as a Regulator of Embryonic Stem Cell Identity  Thomas G. Fazzio, Jason T. Huff, Barbara Panning 
Volume 21, Issue 9, Pages (November 2017)
Volume 10, Issue 3, Pages (September 2006)
Volume 20, Issue 13, Pages (September 2017)
Epigenetic Memory and Preferential Lineage-Specific Differentiation in Induced Pluripotent Stem Cells Derived from Human Pancreatic Islet Beta Cells 
Volume 21, Issue 4, Pages (October 2017)
Kiran Batta, Magdalena Florkowska, Valerie Kouskoff, Georges Lacaud 
Volume 3, Issue 4, Pages (October 2008)
Volume 7, Issue 1, Pages (July 2016)
Volume 16, Issue 3, Pages (July 2016)
Volume 23, Issue 2, Pages (April 2018)
MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
Volume 32, Issue 5, Pages (May 2010)
Short Telomeres in ESCs Lead to Unstable Differentiation
Volume 17, Issue 4, Pages (October 2015)
Volume 20, Issue 13, Pages (September 2017)
Volume 9, Issue 4, Pages (October 2017)
Shipra Das, Olga Anczuków, Martin Akerman, Adrian R. Krainer 
Volume 12, Issue 2, Pages (February 2019)
Volume 6, Issue 3, Pages (March 2016)
Pax6 Is a Human Neuroectoderm Cell Fate Determinant
Volume 26, Issue 3, Pages (March 2018)
Genome-wide Functional Analysis Reveals Factors Needed at the Transition Steps of Induced Reprogramming  Chao-Shun Yang, Kung-Yen Chang, Tariq M. Rana 
Volume 14, Issue 6, Pages (February 2016)
Volume 20, Issue 5, Pages (August 2017)
Volume 12, Issue 2, Pages (February 2013)
Volume 13, Issue 3, Pages (September 2019)
Volume 9, Issue 4, Pages (October 2017)
Global Splicing Pattern Reversion during Somatic Cell Reprogramming
Yasuhiro Yamada, Hitomi Aoki, Takahiro Kunisada, Akira Hara 
Presentation transcript:

Volume 15, Issue 6, Pages 1359-1368 (May 2016) OVOL2 Maintains the Transcriptional Program of Human Corneal Epithelium by Suppressing Epithelial-to-Mesenchymal Transition  Koji Kitazawa, Takafusa Hikichi, Takahiro Nakamura, Kanae Mitsunaga, Azusa Tanaka, Masahiro Nakamura, Tatsuya Yamakawa, Shiori Furukawa, Mieko Takasaka, Naoki Goshima, Akira Watanabe, Keisuke Okita, Satoshi Kawasaki, Morio Ueno, Shigeru Kinoshita, Shinji Masui  Cell Reports  Volume 15, Issue 6, Pages 1359-1368 (May 2016) DOI: 10.1016/j.celrep.2016.04.020 Copyright © 2016 The Authors Terms and Conditions

Cell Reports 2016 15, 1359-1368DOI: (10.1016/j.celrep.2016.04.020) Copyright © 2016 The Authors Terms and Conditions

Figure 1 TFs that Inhibit iPSC Induction in CECs Tend to Regulate Epithelial Development (A) Schematic figure of the iPSC induction assay. (B) The ratio of AP-positive colonies induced from CECs (two independent experiments). OSKM with empty vector = 1. (C) GO term analysis by dividing whole TFs into five groups according to the inhibition order. TFs involved in epithelial lineage development were enriched in TFs 1–30. See also Figure S1 and Table S1. Cell Reports 2016 15, 1359-1368DOI: (10.1016/j.celrep.2016.04.020) Copyright © 2016 The Authors Terms and Conditions

Figure 2 Combined Overexpression of Inhibitory TFs Induced the Transcriptional Program of CECs in Human Fibroblasts (A) The morphology of neonatal human fibroblasts, fibroblasts transduced with GFP, and fibroblasts transduced with 25 TFs. Scale bars, 200 μm. (B) The effect of removing individual TFs from the pool of 25 TFs was examined by qRT-PCR (all n = 4). Data are shown as means ± SD. (C) Phase contrast and immunocytochemistry of K3, K12, and E-cadherin in fibroblasts and fibroblasts with 6 TFs (6TFs-fib). Scale bars, 20 μm. (D) Fluorescence-activated cell sorting (FACS) analysis using Claudin 1 (CLDN1) antibody. (E) Quantitative analysis of CEC-specific genes, fibroblast-specific genes, and endogenous OVOL2 and PAX6 in the indicated cells (all n = 4). Data were analyzed using the unpaired t test and are shown as means ± SD. ∗p < 0.05, ∗∗p < 0.01. (F) Unsupervised hierarchical analyses of global gene expression. (G) ATAC-seq peaks in the promoter regions of CEC-specific genes and fibroblastic-specific genes (all n = 4). (H) Comparison of ATAC-seq peaks at the global level. Numbers represent peak numbers detected by Hotspot software. See also Figure S2 and Table S2. Cell Reports 2016 15, 1359-1368DOI: (10.1016/j.celrep.2016.04.020) Copyright © 2016 The Authors Terms and Conditions

Figure 3 OVOL2 Repressed Mesenchymal Genes in CECs (A) Knockdown of OVOL2 using siRNA (siOVOL2) in CECs and downregulation of CEC-specific genes based on qRT-PCR (all n = 4). Data were analyzed using the unpaired t test and are shown as means ± SD. ∗∗p < 0.01. (B) Western blotting of K12 in primary CECs treated with two siRNAs for OVOL2. (C) The morphology of CECs and CECs treated with siOVOL2. Scale bars, 20 μm. (D) Immunocytochemistry of K12 and E-cadherin in CECs and CECs treated with siOVOL2. Scale bars, 20 μm. (E) Barrier function was assessed by measuring transepithelial electrical resistance (TER) with a volt-ohm meter. (F) Barrier function assay demonstrated that siRNA for OVOL2 reduced the TER compared to control. Representative results of two independent experiments with technical triplicates are shown as means ± SD. Data were analyzed using the unpaired t test. ∗∗p < 0.01. (G) Scatter plots analysis of gene expressions between CECs and CECs treated with siOVOL2 found upregulated genes (320 genes) and downregulated genes (485 genes). (H) GO analysis showed that epithelial-related genes were enriched in DOWN genes. (I) ChIP-seq analysis of OVOL2 in the CECs. (J) Quantitative analysis of CDH1 in the CECs and CECs overexpressing ZEB1 or ZEB2 (all n = 3). Data were analyzed using the unpaired t test and are shown as means ± SD. ∗p < 0.05. GFP-transduced CECs were used as control. (K) Immunocytochemistry of CDH1 in CECs and CECs overexpressing ZEB1 or ZEB2. GFP-transduced CECs were used as control. (L) Barrier function assay demonstrated that overexpression of ZEB1 or ZEB2 in CECs reduced the TER compared to the control (GFP-transduced CECs). Representative results of four independent experiments with technical triplicates are shown as means ± SD. Data were analyzed using the unpaired t test. ∗∗p < 0.01. See also Figure S3 and Table S3. Cell Reports 2016 15, 1359-1368DOI: (10.1016/j.celrep.2016.04.020) Copyright © 2016 The Authors Terms and Conditions

Figure 4 OVOL2 Overexpression Induced the Transcriptional Program of CECs in Neural Progenitor Cells by Regulating Genes Involved in EMT (A) Microarray analyses of EMT-related genes among CECs, epidermal keratinocytes (EDK), adipose-derived stem cells (ASC), dermal fibroblasts (HDF), NPCs, neuroectoderm (NE), iPSCs, and ESCs. (B–D) Ten days after viral infection. (B) The morphology of NPCs overexpressing OVOL2. Scale bars, 20 μm. (C) Quantitative analysis of CEC-specific genes and NPC-specific genes (all n = 4). Data were analyzed using the unpaired t test and are shown as means ± SD. ∗∗p < 0.01. (D) The expressions of EMT-related genes reciprocate with the overexpression of OVOL2. Two individual experiments were performed. (E and F) Three days after viral infection. Data were analyzed using the unpaired t test and are shown as means ± SD. ∗∗p < 0.01. (E) Zeb1 and Zeb2 were downregulated in NPC overexpressing OVOL2. (F) OVOL2 activated, but Zeb1 repressed Krt12 and Cdh1 gene expressions in NPC. (G) Schematic figure of the mechanism shows how the transcriptional profile between CEC and NPC is distinguished. See also Figures S3 and S4. Cell Reports 2016 15, 1359-1368DOI: (10.1016/j.celrep.2016.04.020) Copyright © 2016 The Authors Terms and Conditions